Daimler slumps as diesel costs wipe out profit growth
June 24, 2019China says both U.S., China should make compromises in trade talks
June 24, 2019Bristol to divest Celgene’s psoriasis treatment in FTC clearance push
at
Bristol-Myers Squibb Co said on Monday it would divest Celgene Corp’s psoriasis treatment Otezla as the companies look to gain approval for their $74 billion deal from the U.S. Federal Trade Commission (FTC).
Powered by WPeMatico
